Bayer (BAYRY)
(Delayed Data from OTC)
$7.99 USD
+0.62 (8.41%)
Updated Aug 16, 2024 01:14 PM ET
3-Hold of 5 3
B Value D Growth B Momentum C VGM
Price, Consensus and EPS Surprise
BAYRY 7.99 +0.62(8.41%)
Will BAYRY be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for BAYRY based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for BAYRY
Pharma Stock Roundup: LLY, NVO, BAYRY Q2 Earnings, MRK's New Deal & Other Updates
Bayer (BAYRY) Q2 Earnings In Line, Nubeqa, Kerendia Boost Sales
BAYRY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Regeneron (REGN) Tops on Q2 Earnings, Eylea HD, Dupixent Fuel Sales
Roche (RHHBY) Sales, Earnings Grow in 1H24, '24 EPS View Raised
Bayer (BAYRY) Meets Primary Goal in Nubeqa Expanded-Use Study
Other News for BAYRY
Applied Materials, H&R Block report quarterly beats: Morning Buzz
Bayer surges in Europe after appeals court win in Roundup cancer case
Bayer Roundup appeal wins in Philadelphia court, Bloomberg says
J.P. Morgan Remains a Hold on Bayer (0P6S)
Bayer scores significant win in cancer litigation over Roundup weedkiller